Stock Market Today: Broadcom Slide Fuels Nasdaq Decline

The Federal Reserve has announced a quarter-point interest rate cut, reducing the target range to 3.5% to 3.75%. This decision is expected to provide some relief to borrowers, although it is noted that long-term payments may not see significant changes as they are influenced by other factors beyond the Fed's benchmark rates.

Wall Street is experiencing fresh concerns regarding artificial intelligence (AI) spending, as shares of Broadcom and Oracle have declined significantly, contributing to a volatile week for the markets. Broadcom's stock fell sharply after failing to meet investor expectations, while Oracle's disappointing earnings report further exacerbated the situation.

Aspire Biopharma has received an extension from Nasdaq to meet its listing requirements, allowing the company additional time to comply with the exchange's standards. This extension is crucial for maintaining its status on the Nasdaq stock exchange, which is vital for its visibility and access to capital markets.

The S&P 500 index experienced a notable decline, driven primarily by a significant drop in Broadcom's stock, which fell sharply after the company failed to meet investor expectations regarding its artificial intelligence prospects. This downturn reflects broader concerns in the tech sector, particularly following disappointing earnings from other major players like Oracle.

US tech stocks, particularly those of Broadcom, experienced a significant decline, with Broadcom's shares tumbling 11.4% following a disappointing financial forecast that failed to meet Wall Street expectations. This downturn reflects growing investor concerns about the sustainability of the AI boom and its impact on tech valuations.

Bank of America has reset its stock price target for Broadcom following the company's Q4 earnings report, where CEO Hock Tan highlighted a significant year-over-year growth in their custom-accelerated business. This growth reflects increased adoption of custom accelerators by customers in AI training processes.

The Nasdaq and Russell 2000 indices experienced a decline of over 1% on December 12, 2025, continuing a downward trend in the technology sector. This negative sentiment reflects ongoing concerns among investors regarding the stability and future performance of tech stocks.

VSee Health's stock has seen a significant increase following the company's successful regaining of compliance with Nasdaq's listing requirements. This development marks a positive turnaround for the company, which had previously faced challenges regarding its stock status on the exchange.